A self-proclaimed Brazil-Italy collaboration enthusiast, researcher Laura Bolognesi created the B2AlzD2 Joint Lab at the Department of Pharmacy and Biotechnology of the Università di Bologna (UNIBO), the first Brazil-Bologna joint laboratory dedicated to the development of new drugs for the treatment of Alzheimer’s disease. The partners include scientists from four Brazilian universities: the Federal University of Rio de Janeiro (UFRJ), the University of Brasília (UnB), the University of São Paulo (USP Ribeirão Preto) and the Federal University of Minas Gerais (UFMG).
This article was originally published on MedicalXpress.com
